Walleye Capital’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Walleye Capital's DYN Position: Q3 2026 in Review
Walleye Capital opened a new position in Dyne Therapeutics (DYN) in Q3 2026: 149,707 shares worth $2.41M. The stake represents ﹤0.01% of the portfolio and ranks #2639 among its holdings. This is a return to the name: Walleye Capital previously reported a position in DYN as recently as Q4 2025.
Walleye Capital first reported a position in DYN in Q1 2021 and has held it in 6 quarters since. The position peaked at $3.02M in Q2 2024. 270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Walleye Capital held 149,707 shares of Dyne Therapeutics worth $2.41M as of Q3 2026.
- Dyne Therapeutics was a new Walleye Capital position in Q3 2026.
- Dyne Therapeutics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2639 holding.
- Walleye Capital first reported a position in Dyne Therapeutics in Q1 2021 and has held it in 6 quarters since.
- Walleye Capital's Dyne Therapeutics position peaked at $3.02M in Q2 2024.
- 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.